MARKET

CSTL

CSTL

Castle Biosciences
NASDAQ
24.16
-0.07
-0.29%
After Hours: 24.16 0 0.00% 16:32 07/17 EDT
OPEN
23.79
PREV CLOSE
24.23
HIGH
24.34
LOW
23.59
VOLUME
242.89K
TURNOVER
--
52 WEEK HIGH
44.28
52 WEEK LOW
14.59
MARKET CAP
732.77M
P/E (TTM)
-56.2515
1D
5D
1M
3M
1Y
5Y
1D
Castle Biosciences CEO Derek J. Maetzold disposes of 550 common shares worth $12,606‬‬
PUBT · 2d ago
Castle Biosciences wins NY health department approval for AdvanceAD-Tx test
PUBT · 4d ago
CASTLE BIOSCIENCES ANNOUNCES NEW YORK STATE DEPARTMENT OF HEALTH APPROVAL OF ITS ADVANCEAD-TX™ TEST
Reuters · 4d ago
Weekly Report: what happened at CSTL last week (0706-0710)?
Weekly Report · 5d ago
Castle Biosciences schedules second-quarter results webcast
PUBT · 07/09 11:01
Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026
PR Newswire · 07/09 11:00
Castle Biosciences COO Kristen Oelschlager sells 8,586 shares for $209,041.2
PUBT · 07/06 20:25
Weekly Report: what happened at CSTL last week (0629-0703)?
Weekly Report · 07/06 09:50
More
About CSTL
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers around six commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology ophthalmology and includes a test to guide systemic treatment decisions in patients with moderate-to-severe AD. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for patients with cutaneous squamous cell carcinoma (SCC).

Webull offers Castle Biosciences Inc stock information, including NASDAQ: CSTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSTL stock methods without spending real money on the virtual paper trading platform.